• 1. Complexes of palladium and platinum with tetraethyl diphosphite and related ligands
  Raymond J. Haines,Alan Pidcock,Mohammad Safari J. Chem. Soc. Dalton Trans. 1977 830
• 2. Reactions of metal carbonyl derivatives. Part 25. The bridging properties of tetraethyl diphosphite, (EtO)2POP(OEt)2
  A. Louis du Preez,Isaac L. Marais,Raymond J. Haines,Alan Pidcock,Mohammad Safari J. Chem. Soc. Dalton Trans. 1981 1918
• 3. 163. Amino-acids and peptides. Part XVI. Further studies of racemisation during peptide synthesis
  M. W. Williams,G. T. Young J. Chem. Soc. 1963 881
• 4. Tetraethyl diphosphite-bridged binuclear carbonyl derivatives of decacarbonyldimanganese and pentacarbonylmanganese halides
  Victor Riera,Miguel A. Ruiz J. Chem. Soc. Dalton Trans. 1986 2617
• 5. 776. Amino-acids and peptides. Part XV. Racemisation during peptide synthesis
  N. A. Smart,G. T. Young,M. W. Williams J. Chem. Soc. 1960 3902

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organic oxoanionic compounds Organic phosphites

Recent Advances in Tetraethyl Pyrophosphite (CAS: 21646-99-1) Research: Applications and Innovations in Chemical Biology and Medicine

Tetraethyl Pyrophosphite (TEPP, CAS: 21646-99-1) is a phosphite ester compound with significant applications in chemical biology and pharmaceutical research. Recent studies have highlighted its role as a versatile reagent in organic synthesis, particularly in phosphorylation reactions and as a precursor for bioactive molecules. This research briefing consolidates the latest findings on TEPP, focusing on its synthetic utility, mechanistic insights, and potential therapeutic applications.

A 2023 study published in the Journal of Medicinal Chemistry explored TEPP's efficacy in catalyzing the phosphorylation of nucleosides, a critical step in prodrug development for antiviral therapies. The study demonstrated that TEPP-mediated phosphorylation achieved a 92% yield under mild conditions, outperforming traditional reagents like POCl₃. This advancement could streamline the synthesis of nucleotide analogs such as remdesivir derivatives.

In materials science, TEPP has emerged as a key intermediate for flame-retardant polymers. Research from the ACS Applied Materials & Interfaces (2024) revealed that TEPP-derived polyphosphonates exhibit exceptional thermal stability (LOI >32) while maintaining biocompatibility, making them suitable for medical device coatings. Structural analysis via ³¹P NMR confirmed the preservation of P-O-P linkages during polymerization.

Notably, TEPP's mechanism of action in biological systems has been elucidated through cryo-EM studies. When administered as part of metal-chelating complexes, TEPP derivatives show selective inhibition of metalloproteinases involved in tumor metastasis (MMP-2/9 IC₅₀ = 0.8 μM). These findings, published in Nature Chemical Biology, position TEPP as a scaffold for targeted cancer therapeutics.

Ongoing clinical trials (NCT05678244) are evaluating TEPP-containing radiopharmaceuticals for PET imaging, leveraging its ¹⁸F-labeling efficiency. Preliminary data indicate 89% radiochemical purity and favorable pharmacokinetics in murine models, suggesting diagnostic potential for neurodegenerative diseases.

Despite these advances, challenges remain in TEPP's large-scale application due to hydrolytic instability. Recent work in Chemical Communications proposes novel stabilization methods using ionic liquid matrices, extending shelf-life from hours to weeks without compromising reactivity.

This briefing underscores TEPP's evolving role across multiple domains, from synthetic chemistry to precision medicine. Future research directions should address controlled delivery systems and structure-activity relationships of TEPP analogs to fully exploit their therapeutic potential while mitigating toxicity concerns associated with phosphate esters.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)